异嗜性抗体对不同免疫分析平台TSH测定的干扰
本文报告一例53岁女性甲状腺乳头状癌根治术后患者,其Siemens Advia Centaur XP平台TSH结果未受抑制(5.73和6.61 μIU/ml)。用Siemens、Abbott、Roche和Beckman四个平台检测TSH分别为5.52、0.54、0.12和<0.015 μIU/ml;经异嗜性抗体阻断剂预处理后,Siemens、Abbott和Roche结果显著下降至0.003、0.001和0.005 μIU/ml,证实异嗜性抗体干扰多个检测系统。
要点
- 甲状腺功能结果与临床表现不符时需警惕异嗜性抗体干扰。
- 不同免疫分析平台对异嗜性抗体干扰的敏感性存在差异。
- 异嗜性抗体阻断剂预处理可帮助确认干扰的存在。
核心结论
- 患者样本中的异嗜性抗体干扰了多个免疫分析系统的TSH测定。
- 临床医生应意识到甲状腺功能检测(包括FT4、FT3和TSH)可能存在分析干扰。
研究设计与样本
- 病例报告:53岁女性甲状腺乳头状癌根治术后患者。
- 使用Siemens、Abbott、Roche和Beckman四个平台检测TSH,并进行异嗜性抗体阻断剂预处理。
主要发现
- Siemens Advia Centaur XP术后TSH结果为5.73和6.61 μIU/ml,未受抑制。
- 四个平台TSH结果分别为5.52、0.54、0.12和<0.015 μIU/ml。
- 阻断剂预处理后Siemens、Abbott和Roche结果分别显著下降至0.003、0.001和0.005 μIU/ml。
临床怎么用
- 当甲状腺功能检测结果与患者临床表现不符时,应考虑异嗜性抗体干扰的可能。
- 可通过不同平台比对或异嗜性抗体阻断剂预处理来确认干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Interference due to the presence of heterophilic antibodies may lead to falsely low or high analyte concentrations, but falsely elevated values are more common in most immunoassay platforms. We report a case of a 53-y old female patient underwent radical thyroidectomy for thyroid papillary carcinoma and the results of TSH in the Siemens Advia Centaur XP after surgery were not suppressed, ranging from 5.73 and 6.61 μIU/ml. METHODS: The status of the thyroid was then assessed using 4 assay platforms from Siemens, Abbott, Roche and Beckman. RESULTS: The results of TSH were 5.52, 0.54, 0.12, and <0.015 μIU/ml, respectively. After the samples were pretreated with the heterophilic antibody blocker, results given by Siemens, Abbott, and Roche showed significant decreases of 0.003, 0.001, and 0.005 μIU/ml, respectively. Therefore, it was confirmed that the presence of heterophilic antibodies in the patient samples interfered with the TSH measurements in multiple assay systems. CONCLUSIONS: Clinicians must be aware of the possible assay interference, including the measurements of FT4, FT3 and TSH, results may be misleading in the presence of heterophilic antibodies, in particular when the results of thyroid function tests do not fit the patient clinical presentation.
引用
- Cheng X, Guo X, Chai X, et al. Heterophilic antibody interference with TSH measurement on different immunoassay platforms. Clin Chim Acta. 2020. PMID: 33285118. doi:10.1016/j.cca.2020.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。